chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I work up feeling better, and more alert  than I had been in years. I felt reborn. Alive. Hard to explain. I was so happy. Hoped it wasnt a one day thing.; chills; fever; body aches; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Lot number: ER8727), via an unspecified route of administration in the right arm on 22Mar2021 at 16:30 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. Medical history included thyroidectomy, high blood pressure, depression and COVID-19 in Nov2020 (during the first week the patient had fever, chills and aches. The fatigue took 3 more weeks to recover). The patient reported that she took medications (unspecified) within the two weeks prior to the COVID-19 vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6203), via an unspecified route of administration in the right arm on 01Mar2021, at 16:30, (at the age of 65-years-old) as a single dose for COVID-19 immunisation. The patient underwent a COVID-19 virus test and was tested positive in Nov2020. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 23Mar2021, at 07:00 the patient experienced expected chills, fever, and body aches. The next morning the patient woke up and felt better and more alert than the patient had been in years. The patient felt reborn and alive and found it hard to explain. The patient also felt happy and hoped it was not a one-day thing. She felt the same 3 days later and felt better than ever before in years and felt the need to make someone aware of her situation. The patient considered it to be a truly a miracle. The therapeutic measure included intake of one 500 TYLENOL for the events on 23Mar2021 at 16:00. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcomes of the events were resolved with sequelae on 24Mar2021.   No follow-up attempts are needed. No further information is expected.
Menstrual cycle came 2 weeks early with increased cramping; Menstrual cycle came 2 weeks early with increased cramping; This is a spontaneous report from a contactable consumer (patient). A 33-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration administered in left arm on 23Feb2021 12:30 (at the age of 33-year-old) (Batch/Lot Number: EM9809) as 2ND DOSE, SINGLE for COVID-19 immunisation. The patient was not pregnant at the time of vaccination. The patient had no other vaccine in four weeks. The patient had no COVID prior to vaccination. The patient's medical history and concomitant medications were not reported. The patient had known allergies with diclofenac. Historical vaccine includes bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: EL9265), administered in the left arm on 02Feb2021 at 12:30 PM (at the age of 33-year-old) for COVID-19 immunization. On 04Mar2021 at 12:00 PM, the patient experienced menstrual cycle came 2 weeks early with increased cramping. No treatment was received for the events. It was also reported that patient was tested for COVID post vaccination via nasal swab on 04Feb2021 which was negative. The patient had not yet recovered from the events.
had sl fever & sore arm that afternoon-Sunday had a  stomachache, vomited later Sunday noc-Monday playing quietly
Experienced Appendicitis after receiving the Moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of APPENDICITIS (Experienced Appendicitis after receiving the Moderna vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In May 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced APPENDICITIS (Experienced Appendicitis after receiving the Moderna vaccine) (seriousness criterion medically significant). At the time of the report, APPENDICITIS (Experienced Appendicitis after receiving the Moderna vaccine) outcome was unknown.            Concomitant product use was not provided by the reporter.   No treatment information was provided. Company Comment This case concerns a female patient of unknown age, with no relevant medical history reported, who experienced the unexpected event of appendicitis (AESI). The event occurred on an unknown number of days after the second dose of mRNA-1273. The rechallenge was not applicable since the events happened after the second dose. The benefit-risk relationship of mRNA-1273 is not affected by this report.; Sender's Comments: This case concerns a female patient of unknown age, with no relevant medical history reported, who experienced the unexpected event of appendicitis (AESI). The event occurred on an unknown number of days after the second dose of mRNA-1273. The rechallenge was not applicable since the events happened after the second dose. The benefit-risk relationship of mRNA-1273 is not affected by this report.
Several hours after receiving the vaccination, she began itching on both arms with a red rash, neck and face became flushed.  Injection site was also painful. She went to employee health and they sent her to urgent care.  She was told to take oral benedryl.  She felt unwell for several days and developed hives 48 hours after the injection.  Followed up with urgent care after a week. Symptoms resolved.
This spontaneous report as received from a Doctor of pharmacy refers to a patient of unknown age. The patient was vaccinated with an expired dose of ZOSTAVAX (Lot # 671454/1125AA, expiration date 12-OCT-2012) on 16-OCT-2012. This is one of several reports received from the same source. Additional information has been requested.
Moderna COVID?19 Vaccine EUA - TINGLING THROUGHOUT FACE, ARMS, LEGS, HANDS, FEET.  MORE SEVERE ON RIGHT SIDE, RED RASH ON FACE, STILL ONGOING AND WORSE AFTER 2ND VACCINE ON 4/16/21.  BEEN ON STERIODS AND OTHER MEDS SINCE INITIAL SYMPTOMS ON 4/2.  HAVE HAD SCANS, BRAIN MRI, TESTING FOR AUTO IMMUNE DISEASES, MS, ETC AND ALL COME BACK NEGATIVE.  BEING TOLD MOST LIKELY FROM VACCINE.  WHAT AM I TO DO ABOUT THIS FOR REST OF MY LIFE???
Wednesday the 17 of January 2018 Patient received the shot. Thursday the 18 of January 2018 the patient experienced extremely Itchy eyes and "wanted to scratch her eyes out" also compared it to her cat allergies explaining it was that bad along with Asthma like Symptoms. Friday the 19 of January 2018 the itching was still bad did not attend work and reported that the asthma was better. Saturday the 20 of January 2018 reported that both the itching/ asthma were better and was planning on leaving for vacation. The patient experienced at the site of the injection red, tender, swollen skin which by Saturday the 20 of January had changed to purple was still tender but the swelling was reduced. Patient called the pharmacy on the 20 of January 2018 and reported signs and symptoms was recommended to call her primary care provider if the symptoms worsen.
Within 5 minutes of receiving vaccine, vaccination site was bruised, discolored, & knotted.
Client presented to receive Pfizer booster. Client reported  that his first dose went well, however when he received his second dose he felt dizziness/weakness two hours after receiving the second dose on March 17th, 2021. He stated that it lasted 10mins and decided to take Ibuprofen and it went away. He stated the symptoms didn't come back. Client states he had something to eat that day, however he stated he had waited in line for many hours prior to getting vaccinated , he believes that might have caused him to feel dizzy. Medical Consultation was sent to Vaccine supervisors and client was approved to receive Pfizer booster lot#FF8839 on 11/9/21. Prior to vaccination client was given bottled water and crackers. Client was instructed to seek emergency care for any anaphylaxis reaction. Also, to speak to his primary care provider for any non emergency symptoms he might experience. He was instructed to stay well hydrated and eat his meals. Client verbalized understanding. Client walked to observation area after receiving vaccine in a steady gait.
Day 2 arm started to be sore from injection site, became worse every day and debilitatingly sore for 3 1/2 weeks. My Dr. ordered x rays to detect fluid. Very difficult to put on my clothes, aches in legs first week. No doubt that it was the shot.
Developed chills, body aches and pains, 99.3°F at night, and had a headache. The next day (3/26) my temperature was back to normal, body aches and pains were gone but had a migraine.  On 3/27, I took 1000mg of Tylenol around 6pm for the migraine and took a few hours for it to subside. I was feeling 100% by Monday, 3/29.
A large red rash (approximately 2 inches x 1 inch) appeared on left arm close to injection site. It does not itch and is not sore. Just red.
Severe chills and cramps, joint pain, cold sweating but no fever. My skin felt like it was on fire
I woke up on Sunday morning and the left side of my upper lip was completely swollen, I took Benadryl and waited 2 hours which did not help the swelling. I then went to urgent care where they prescribed me steroids and allergy medicine to help.
Patient female 26 years old received a dose Janssen lot-1805018 in the associated medical facilities on March 20, 2021. Patient came in July 17, 2021 in the vaccination center of to receive her first Moderna vaccine lot 039C21A since she said she was worried of the effectness of Janssen and her health conditions of diabetes, hx of cancer thyroid and being a care giver of the elderly, It is for this reason that she agrees to have omitted the information from the previous vaccination of Janssen.
She is having an extreme pain joint and muscle pain; She is having an extreme pain joint and muscle pain; This is a spontaneous report from a contactable consumer (Husband). A female patient (Wife) of an unspecified age received second dose of bnt162b2 (PFIZER COVID-19 VACCINE: solution for injection; Lot number: not reported) via an unspecified route of administration on an unspecified date as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Historical vaccine included first dose of bnt162b2 on an unspecified date for covid-19 immunisation. On an unspecified date, Reporter Stated, I am calling on behalf of my wife she had her second dose of Pfizer vaccine and she is having an extreme pain joint and muscle pain and I was wondering what is okay for her to take to help her relieve that or anything at all (Unspecified Medication). The outcome of the events was unknown.  Information about the Lot/batch number has been requested.
SEVERE TINNITUS; This spontaneous report received from a consumer via a company representative concerned multiple patients. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for covid-19 prophylaxis. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced severe tinnitus. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of severe tinnitus was not reported. This report was non-serious. This case, from the same reporter is linked to 20221243340, 20221243261, 20221243606, 20221245881, 20221245816 and 20221245969.
Patient was vaccinated on 02/01/08 and the symptoms of the event started on 02/08/08.  Patient experienced a variety of symptoms over a period of two months including myalgias, arthralgia, pelvic pain, jaw claudication and double vision.  Patient said that she was currently suffering from knee and joint swelling and has difficulty climbing stairs.  Patient was also experiencing night sweats.  Follow up obtained on 04/11/2008:  Patient has a history of chronic Lyme disease.  Patient developed diffuse arthralgia and myalgia approximately one week after receiving TD vaccine.  Several weeks after the onset of these symptoms she noted the onset of pelvic and severe jaw pain, which she described as "bone on bone".  More recently she developed problems with double vision and was undergoing an evaluation by a neurologist.  All of these symptoms have persisted with varying intensities during the past two months.  She was unable to recall if any of these symptoms occurred after she last received a TETANUS vaccination.  Follow up obtained on 05/08/08:  Additional history regarding the chronology of the initial events was obtained in addition to obtaining follow up information since 04/11/08.  On 03/12/08 patient had been seen by a neurologist after experiencing a dissociative episode and diplopia lasting several hours.  Carotid studies, MRA and EEG were unrevealing.  She also underwent pelvic ultrasound which was negative.  Right knee pain and effusion developed approximately 1.5 to 2 months after receiving TD vaccine, and evaluation by a rheumatologist and orthopedic surgeon along with MRI have demonstrated degenerative joint disease and osteoarthritis.  She has been prescribed anti-inflammatory medication for this problem.  All of these symptoms have resolved, with the exception that the right knee pain has persisted.
Multiple welts with surrounding erythema on arms, legs, and torso with itchiness.
Age:75 y.o. Admit Date:  7/6/2022 Discharge Date:  7/17/2022      Principal Diagnoses:  Principal Problem:   Acute on chronic respiratory failure with hypoxemia     Discharge Diagnosis:  Acute on chronic hypoxic respirtory failure, COVID 19, Afluter, Hypotension, dilated cardiomyopathy, Dm2,    Hospital Course:  The patient was admitted with the above. She was treated with 5/5 days remdesevir and 10 days steroids. She improved back to her baseline of 2 liters home oxygen. He was noted to have an elevated troponin on admission and cardiology was consulted. They felt that it was a type 2 MI due to COVID 19. 2D echo showed an E fof 45-50%., We tried to place her on entresto and metprolol but she became hypotensive with this. Her metoprolol was decreased to 12.5 mg po BID and she was placed on lisinipril 2.5 mg po daily and she seemed to tolorate this. She was debilitated on dischrge so she was sent to a nursing home for rehab.    Consults to: Cardiology.   Significant Diagnostic Studies: 2D echo.    Procedure(s): None.    Disposition:  SNF   Discharge Condition:  fair
Delayed cutaneous hypersensitivity reaction  Narrative: onset of delayed hypersensitiving reaction (rash, irregular boarders) within 48 hours of 1st dose. Rash resolved over 4 days without treatment.   Other Relevant History:
patient was admitted to the hospital on 8/10 @4am. His diagnosis is COVID Pneumonia. She stated his symptoms began on 8/4 with fever and body aches and diarrhea and nausea. She said he went to be tested on 8/6 and tested negative but was very sick with symptoms. then tested again and was positive on 8/10. She stated he has a history of Diabetes and hypertension and has Obesity
Monday after my first dose my left ear felt full and hearing was muffled.  Went to urgent care and it was said to be outer ear infection and gave antibiotic drops.  Two weeks later my ear still felt full, slight ringing and muffled hearing.  Went to ENT who diagnosed Eustachian tube disorder., which I?ve never had before.  He put me on Flonase, low dose omeprazole and  sinus rinse.  One week after my initial ENT appointment,  the problem still persists.  I just had my second dose on 04/26 (lot number 048B21A in left arm).  I don?t feel congested or sick, just full left ear and muffled hearing in left ear.    Given that the symptoms happened less than a week after first shot, I wanted to report as possible adverse event; particularly because I saw a report that  on drug discovery trends that Tinnitus is an issue people have reported.   I go back to the ENT on  May 14th to see if there is any improvement.  Note for question 15 - it was not sure if you meant the facility for my doctor I saw (Dr. and  ENT) or the facility where I had my shot .  I put the facility where I had my vaccine.
Fever , sleepery, weakness , chilling ,poor vision for 5 days, absense of appetite .Difficult breathing .
Generalized seizure, went to hospital. EEG recorded as normal, neurology follow up recom.
w/in past 6mo pt recv vax & presents to ER w/herpes zoster, lt thoracic shingles;MD dx shingles on physical exam of vesicles in ER;
Second dose was scheduled 13 days after the first dose; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose was scheduled 13 days after the first dose) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039V28) for COVID-19 vaccination.     No Medical History Information was reported.  Concomitant products included DARUNAVIR ETHANOLATE (PREZISTA) for AIDS, ROSUVASTATIN for an unknown indication.    On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose was scheduled 13 days after the first dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose was scheduled 13 days after the first dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided. Concomitant Rosuvastatin indication was reported as virus. Patient received her first dose of vaccine on 23-Apr-2021 and was scheduled to receive her second dose on 05-May-2021,which was 13 days post receiving the first dose of vaccine but the patient stated that she missed to receive her second dose. The patient has provided the Lot number as Moderna 039V28 but was unsure about the number.   Most recent FOLLOW-UP information incorporated above includes: On 18-May-2021: Follow up received. Patient denied further follow up
MASSIVE ERYTHEMA, EDEMA,HARDNESS, PAIN INJECTION SITE  PROGRESSED UNTIL 2 DAYS POST INJECTION. ANTIBIOTIC COURSE, STEROID CREAM BEGAN WITH RAPID RECOVERY
A report has been received from a Health Professional concerning a 15 year old, male subject, who had been receiving FLUMIST (INTRANASAL). FLUMIST (INTRANASAL) started on an unknown date. The reporter mentioned that patient was accidentally given expired FLUMIST on 04-Dec-2013. The outcome of the event of WE ACCIDENTALLY GAVE EXPIRED FLUMIST TO A PATIENT is unknown. The report was considered to be non-serious.
The patient received the pneumovax23 and Fluad in the Right Deltoid Arm around 5pm.  The patient had intense arm pain around 9pm and couldn't move his arm. He went to the ER around 2am. They sent him home on pain meds and a muscle relaxer. He has been feeling better and better every day.
Extreme Headache after Second Dose; Extreme High Blood Pressure after Second Dose; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Extreme Headache after Second Dose) and HYPERTENSION (Extreme High Blood Pressure after Second Dose) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Mar-2021, the patient experienced HEADACHE (Extreme Headache after Second Dose) (seriousness criterion hospitalization) and HYPERTENSION (Extreme High Blood Pressure after Second Dose) (seriousness criterion hospitalization). At the time of the report, HEADACHE (Extreme Headache after Second Dose) and HYPERTENSION (Extreme High Blood Pressure after Second Dose) outcome was unknown.            Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
5 inches of redness, swelling, warm to touch and tightness at injection site.
My daughter called me saying she received a tetanus shot (with diptheria) and an influenza shot in her right arm about an hour or so ago and now had a completely numb and tingling right hand. She wasn't doing anything with that hand except sitting in a lecture at school. I told her to return to the medical clinic and report the symptoms. She called back and said they told her it might be a nerve problem from swelling at the injection sight. She was told to monitor symptoms and return to the clinic if they worsen. They also told her to monitor for guillan barre symptoms that could arise in a week or so.
Erythema of both arms, shoulders to hands, less at hands, pink flat macules. Does not itch, no edema no increased warmth. Rash on legs, warm. Temp 99.4 deg. F. On 04/03/2002 pale pink papules on arms and upper legs, non-pruritic. Mild allergy reaction.
mom described redness, swelling of lt deltoid the evening p/vax; swelling inc for several days; MD received rx for Advil PRN & recommended apply cool compresses to arm; MD dx local rxn;
hives; Initial information regarding an unsolicited valid non-serious case received via an other health professional on 13-Nov-2020.  This case involves an unknown age female patient who experienced hives (urticaria), while treated with influenza quadrival a-b high dose hv vaccine [Fluzone high-dose quadrivalent].  The patient's medical history, past medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications were unknown.   On an unknown date, the patient received a dose  dose of suspect influenza quadrival a-b high dose hv vaccine (Lot number and expiry date unknown) at an unknown dose, frequency via unknown route at an unknown site for prophylactic vaccination.  On an unknown date (unknown latency), after starting the suspect vaccine therapy, patient experienced hives (urticaria).   No laboratory data was reported.  It was not reported if the patient received any corrective treatment.  At the time of reporting, outcome of the event was unknown.  There will be no information available on batch number for this case.
Hospitalized with worsening fatigability, shortness of breath with hypoxia to 85%, increased confusion (covid + 1/8/2022)
Swollen left eye, pain, redness, draining.  Redness and itchiness in between fingers, arms.
Moderna Covid Bivalent Booster administered on 12/14/22.  It was later discovered that this person had already received the Moderna Covid Bivalent Booster on 10/14/22 at another facility.   He is denying any side effects/adverse reactions except for a painful injection site.